Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.57 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.57 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | NOD2 | Q9HC29 | 2/20 | 0.43 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | PRKDC | P78527 | 1/20 | 0.42 |
| ▸ | SNCA | P37840 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trans-Asarone SCHEMBL528746 | 1.00 | HMGCR (1.00) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| Cis-Asarone SCHEMBL29655982 | 1.00 | HMGCR (1.00) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| Cis-Asarone SCHEMBL528747 | 1.00 | HMGCR (1.00) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| Trans-Asarone SCHEMBL29433647 | 1.00 | HMGCR (1.00) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| Trans-Asarone SCHEMBL29268894 | 0.98 | HMGCR (0.95) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| Trans-Asarone SCHEMBL30487992 | 0.88 | CYP3A4 (0.78) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| SCHEMBL13498711 | 0.85 | HMGCR (0.73) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| SCHEMBL13324430 | 0.85 | HMGCR (0.73) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| SCHEMBL12621133 | 0.85 | HMGCR (0.73) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| SCHEMBL3486261 | 0.83 | HMGCR (0.70) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250205310-A1 | METHOD FOR REVERSING BODY-WIDE AGE-ASSOCIATED FUNCTIONAL CHANGES | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2025-06-26 | — | — | US | claimed |
| CN-120064478-A | UPLC characteristic spectrum of Happy powder, detection method and application thereof | 杭州百诚医药科技股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-120025234-A | Synthesis method of alpha-asarone | 湖南威特制药股份有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-119915957-A | Thin layer identification method for index components in nerve-soothing and mind-calming pill | 安徽中医药大学 | 2025-05-02 | — | — | CN | claimed |
| CN-119908505-A | Vanillin series electronic atomization liquid, preparation method and electronic atomization device | 思摩尔国际控股有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-116554397-B | Negative electrode binder of lithium battery and preparation method thereof | 深圳市德泰能源有限公司 | 2025-04-22 | — | — | CN | claimed |
| CN-119804725-A | Construction method of multi-index component HPLC content of traditional Chinese medicine powder reference sample | 江苏颐海药业有限责任公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119656213-A | Skin penetrating paste of mugwort leaf medicine needle and its prepn | 山东第二医科大学 | 2025-03-21 | — | — | CN | claimed |
| CN-119638715-A | Efficient preparation method of tetrahydrofuran type lignan Sumatranin A | 西南交通大学 | 2025-03-18 | — | — | CN | claimed |
| CN-119310228-B | Granule fingerprint spectrum for treating debilitating syndrome and establishing method thereof | 中国人民解放军总医院第六医学中心 | 2025-02-25 | — | — | CN | claimed |
| CN-1634589-A | Injection using invert sugar water solution as carrier | YANG XIHONG (CN) | 2005-07-06 | — | — | CN | claimed |
| CN-1615827-A | Medicinal powder injection for respiratory system and preparing method | LIU WANZHONG (CN) | 2005-05-18 | — | — | CN | claimed |
| EP-1487770-A1 | FORMATION OF NEOLIGNAN BY DDQ MEDIATED DIMERISATION OF DIHYDROASARONE | Council of Scientific and Industrial Research;an Indian Reg. body incorporated under Reg. of Societies Act (Act XXI of 1860) (IN) | 2004-12-22 | — | — | EP | claimed |
| CN-1511817-A | Process for producing alpha-asarone raw material | 刘博纯 | 2004-07-14 | — | — | CN | claimed |
| WO-2003082786-A1 | A PROCESS FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE ALPHA-ASARONE FROM TOXIC BETA-ASARONE RICH ACORUS CALAMUS OIL | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-10-09 | — | — | WO | claimed |
| WO-2003080551-A1 | FORMATION OF NEOLIGNAN BY DDQ MEDIATED DIMERISATION OF DIHYDROASARONE | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-10-02 | — | — | WO | claimed |
| US-20030113275-A1 | Process for the preparation of 1-Propyl-2, 4, 5- trimethoxybenzene from toxic beta-asarone of Acorus calamus or from crude calamus oil containing beta-asarone | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2003-06-19 | — | — | US | claimed |
| CN-1363220-A | Method for researching and preparing non-toxic agricultural anthelmintic without environmental pollution | WANG LIHUA (CN) | 2002-08-14 | — | — | CN | claimed |
| US-20020035299-A1 | Process for the preparation of 1-Propyl-2, 4, 5-trimethoxybenzene from toxic beta-asarone of acorus calamus or from crude calamus oil containing beta-asarone | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2002-03-21 | — | — | US | claimed |
| WO-1996029875-A1 | INSECT MONITORING SYSTEMS AND TRAPS | EDWARD BILLINGTON & SON LIMITED (GB) | 1996-10-03 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035299-A1 | Process for the preparation of 1-Propyl-2, 4, 5-trimethoxybenzene from toxic beta-asarone of acorus calamus or from crude calamus oil containing beta-asarone | ADRA2B, CYP1B1, ADRB1 | HMGCR 365/4885CYP3A4 47/4885NFE2L2 2027/4885 |
| US-20030113275-A1 | Process for the preparation of 1-Propyl-2, 4, 5- trimethoxybenzene from toxic beta-asarone of Acorus calamus or from crude calamus oil containing beta-asarone | ADRA2B, CYP1B1, ADRB1 | HMGCR 348/4885CYP3A4 46/4885NFE2L2 2015/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.